A not for profit organisation

Request an appointment

Functional benefits of a chorioretinal anastomosis at 2 years in eyes with a central retinal vein occlusion treated with ranibizumab compared with ranibizumab monotherapy

Home Research Research Publication Functional benefits of a chorioretinal anastomosis at 2 years in eyes with a central retinal vein occlusion treated with ranibizumab compared with ranibizumab monotherapy

Functional benefits of a chorioretinal anastomosis at 2 years in eyes with a central retinal vein occlusion treated with ranibizumab compared with ranibizumab monotherapy.

McAllister IL, Smithies LA, Chen FK, Mackey DA, Sanfilippo PG.

BMJ Open Ophthalmol. 2021 Mar 8;6(1):e000728. doi: 10.1136/bmjophth-2021-000728. eCollection 2021.

PMID: 33768164

Need any help?

If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.

Phone
(08) 9381 0777
Email
carecentre@lei.org.au

Request an appointment